NICE Supports Weekly Insulin Jab for Type 2 Diabetes

Published Date: 21 Aug 2026

Once-weekly insulin efsitora alfa won NICE backing for adults with type 2 diabetes after trials showed glucose control similar to that with established basal insulins, with fewer injections.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Alternative breast imaging techniques beyond mammography.

2.

Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars

3.

Capivasertib Wins Metastatic Prostate Cancer Approval

4.

Fixed-Duration Combo Shows Promise for Relapsed MCL

5.

Q&A: Breast cancer facts that could save lives


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot